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Summary. A lectin histochemical study was performed 
to investigate the glycoconjugate saccharidic moieties on 
the endometrial epithelium and stroma in 12 women 
undergoing controlled ovarian hyperstimulation (COH) 
for in-vitro fertilisation for embryo transfer (IVF-ET) 
in early luteal phase. 7 control subjects were also 
evaluated. For this purpose a battery of seven horse- 
radish peroxidase-conjugated lectins (PNA, SBA, DBA, 
WGA, ConA, LTA and UEA I) was used. Cytochemical 
controls were performed for specificity of lectin-sugar 
reaction. As far as the endometrial glands and stroma are 
concerned, the obtained data showed no differences in 
the endometrial lectin binding between the subjects of 
the control group and the ones undergoing COH, with 
the exception of PNA reactivity at the level of the apical 
portion of the glandular cells, which was detected only 
in COH women. It is noteworthy that, although the 
endometrial dating using the Noyes's criteria showed 
marked dissynchronies between the stroma and the 
glands in COH subjects, a uniformity of lectin binding, 
revealing the same type and localization of terminal 
oligosaccharides, was observed in all the examined 
subjects. The uniformity in distribution of the sugar 
residues detected in the endometrial specimens 
following COH might be due to the massive FSH and/or 
hCG treatment which probably determines an endo- 
metrial environment almost equal in all the examined 
subjects. In all the treated subjects reactivity with 
sialidase-WGA and ConA, revealing the presence of N- 
acetyl -D-glucosamine and D-mannose respectively, was 
detected at the level of the lining epithelium. 
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Introduction 
Controlled ovarian hyperstimulation (COH) is 
frequently associated with morphological alterations of 
the endometrium (Frydman et al., 1982; Cook et al., 
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1984; Graf et al., 1988; Sterzik et al., 1988; Benn-Nun et 
al., 1992; Seif et al., 1992; Benadiva and Metzger, 
1994). 
As far as the endometrial glycoconjugates are 
concerned, many investigations have been carried out on 
the glycoconjugate sugar residue content and distribution 
in endometria from fertile and infertile women, both in 
proliferative and secretive phases (Bychkov and Toto, 
1986; Soderstrom, 1987; Aoki et al., 1989; West and 
Cope, 1989; Klentzeris et al., 1991; Horvat, 1993). 
Moreover, several reports on glycoconjugate terminal 
oligosaccharides in uteri of rodents showed variations 
following hyperstimulation with exogenous gonado- 
trophins (Kramer et al., 1990; Peverini and Kramer, 
1995; Kramer and de Wet, 1994). To our knowledge no 
data are available on the oligosaccharidic distribution in 
human endometria during hyperstimulated cycles. 
The aim of the present research was to investigate 
the oligosaccharidic content and distribution on endo- 
metrial epithelium and stroma in early luteal phase in 
women undergoing COH. 
Materials and methods 
Twelve women aged under 35 and affected by male 
factor infertility undergoing IVF at the Reproductive 
Unit of the Department of Gynecology and Obstetrics, 
Florence University, participated in this study. In these 
women oocytes were collected, but due to failure of 
fertilization embryo transfer (ET) was not made. COH 
was performed by individually adjusted hFSH 
(METRODIN 75 IU/ampoule, Serono, Rome, Italy) 
daily dose from 2 to 4 ampoules. To prevent an untimed 
luteinizing hormone (LH) release patients had been 
pretreated with buserelin acetate (Suprefact, Hoescht 
Roussel, Milan, Italy) 600 mcglday s.c., which started to 
be given during the midluteal phase of the previous 
cycle and continued until the day of human chorionic 
gonadotrophin (hCG) administration. In these patients 
fertilization ended in failure, therefore ET was not 
performed. On day 16 an endometrial biopsy was carried 
out, after a written consent had been obtained. On the 
same day of the menstrual cycle, endometrial biopsies 
were taken from 7 control patients, after a written 





